 | Up a level |
Jump to: Journal Article
Number of items: 1.
Journal Article
Christoph, D. C. C., Rizzo, F., Kambartel, K-O., Winke, S., Panse, J., Abdulla, D. S., Scheffler, M., Azeh, I. T., Hoiczyk, M., Turki, A. and Metzenmacher, M. (2020). Docetaxel/nindetanib as efficient treatment option after failure of immune checkpoint inhibition: Real-world evidence. Ann. Oncol., 31. S. S876 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041